Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality

被引:33
|
作者
Tamburini, Elisa [1 ]
Dallatomasina, Alice [2 ]
Quartararo, Jade [1 ]
Cortelazzi, Barbara [1 ]
Mangieri, Domenica [3 ]
Lazzaretti, Mirca [1 ]
Perris, Roberto [1 ]
机构
[1] Univ Parma, Ctr Mol & Translat Oncol COMT, Parco Area Sci 11-A, I-43124 Parma, Italy
[2] IRCCS, San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy
[3] Univ Foggia, Dept Med Sci, Foggia, Italy
来源
FASEB JOURNAL | 2019年 / 33卷 / 03期
关键词
extracellular matrix; structure-function relationship; macromolecular interactions; signal transduction; CHONDROITIN SULFATE PROTEOGLYCAN; MELANOMA-ASSOCIATED ANTIGEN; CENTRAL-NERVOUS-SYSTEM; HIGH-MOLECULAR-WEIGHT; OLIGODENDROCYTE PRECURSOR CELLS; PDGF ALPHA-RECEPTOR; SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NG2; PROTEOGLYCAN; MONOCLONAL-ANTIBODIES;
D O I
10.1096/fj.201801670R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chondroitin sulfate proteoglycan 4 (CSPG4) gene encodes a transmembrane proteoglycan (PG) constituting the largest and most structurally complex macromolecule of the human surfaceome. Its transcript shows an extensive evolutionary conservation and, due to the elaborated intracellular processing of the translated protein, it generates an array of glycoforms with the potential to exert variant-specific functions. CSPG4-mediated molecular events are articulated through the interaction with more than 40 putative ligands and the concurrent involvement of the ectodomain and cytoplasmic tail. Alternating inside-out and outside-in signal transductions may thereby be elicited through a tight functional connection of the PG with the cytoskeleton and its regulators. The potential of CSPG4 to influence both types of signaling mechanisms is also asserted by its lateral mobility along the plasma membrane and its intersection with microdomain-restricted internalization and endocytic trafficking. Owing to the multitude of molecular interplays that CSPG4 may engage, and thanks to a differential phosphorylation of its intracellular domain accounted by crosstalking signaling pathways, the PG stands out for its unique capability to affect numerous cellular phenomena, including those purporting pathologic conditions. We discuss here the progresses made in advancing our understanding about the structural-functional bases for the ability of CSPG4 to widely impact on cell behavior, such as to highlight how its multivalency may be exploited to interfere with disease progression.Tamburini, E., Dallatomasina, A., Quartararo, J., Cortelazzi, B., Mangieri, D., Lazzaretti, M., Perris, R. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
引用
收藏
页码:3112 / 3128
页数:17
相关论文
共 50 条
  • [1] Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
    Nicolosi, Pier Andrea
    Dallatomasina, Alice
    Perris, Roberto
    THERANOSTICS, 2015, 5 (05): : 530 - 544
  • [2] Functional roles of CSPG4/NG2 in chondrosarcoma
    Jamil, Nuor S. M.
    Azfer, Asim
    Worrell, Harrison
    Salter, Donald M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2016, 97 (02) : 178 - 186
  • [3] The regulatory mechanisms of NG2/CSPG4 expression
    Emmanuel Ampofo
    Beate M. Schmitt
    Michael D. Menger
    Matthias W. Laschke
    Cellular & Molecular Biology Letters, 2017, 22
  • [4] NG2/CSPG4 in glioblastoma: about flexibility
    Finocchiaro, Gaetano
    Pellegatta, Serena
    NEURO-ONCOLOGY, 2019, 21 (06) : 697 - 698
  • [5] The regulatory mechanisms of NG2/CSPG4 expression
    Ampofo, Emmanuel
    Schmitt, Beate M.
    Menger, Michael D.
    Laschke, Matthias W.
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2017, 22 : 1 - 9
  • [6] NG2/CSPG4 and progranulin in the posttraumatic glial scar
    Schaefer, Michael K. E.
    Tegeder, Irmgard
    MATRIX BIOLOGY, 2018, 68-69 : 571 - 588
  • [7] The expression and function of NG2/CSPG4 in human chondrocytes
    Jamil, N. S. M.
    Howie, S. E. M.
    Salter, D. M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2012, 93 (04) : A16 - A16
  • [8] Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers
    Zhang, Hongyu
    Wu, Zhenyu
    Hu, Deyu
    Yan, Min
    Sun, Jing
    Lai, Jiejuan
    Bai, Lianhua
    VACCINES, 2022, 10 (07)
  • [9] NG2/CSPG4 promotes resistance to therapy in glioblastoma multiforme
    Heywood, R.
    Watts, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S784 - S784
  • [10] Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
    Wang, Jian
    Svendsen, Agnete
    Kmiecik, Justyna
    Immervol, Heike
    Skaftnesmo, Kai Ove
    Planaguma, Jesus
    Reed, Rolf Kare
    Bjerkvig, Rolf
    Miletic, Hrvoje
    Enger, Per Oyvind
    Rygh, Cecilie Brekke
    Chekenya, Martha
    PLOS ONE, 2011, 6 (07):